Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-01-26 @ 5:54 PM
Study NCT ID:
NCT06672068
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-12-30
First Post:
2024-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC
Sponsor:
TYK Medicines, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-01
First Submit QC Date:
None
Study First Post Date:
2024-11-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-27
Last Update Post Date:
2024-12-30
Last Update Post Date Type:
ACTUAL